Dashboard
Manage Tickers

CLNN Clene Inc.

Nasdaq clene.com


$ 8.16 nm (nm)    

Monday, 20-Oct-2025 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.01 $ 7.61 (1.26 %)
DIA $ 467.44 $ 5.24 (1.13 %)
SPY $ 672.00 nm (nm)
TLT $ 91.59 nm (nm)
GLD $ 401.08 $ 14.16 (3.64 %)
$ 8.5
$ 8.48
$ 8.12 x 5
$ 9.43 x 600
$ 8.16 - $ 8.84
$ 2.28 - $ 11.06
73,444
na
84.92M
$ 0.73
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-24-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-13-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-13-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-11-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-29-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

d-boral-capital-maintains-buy-on-clene-maintains-23-price-target
D. Boral Capital Maintains Buy on Clene, M...
09/25/2025 12:16:58

D. Boral Capital analyst Jason Kolbert maintains Clene (NASDAQ: CLNN) with a Buy and maintains $23 price target.

clene-to-present-at-ectrims-2025-meeting-sept-24-26
Clene To Present At ECTRIMS 2025 Meeting S...
09/25/2025 12:07:05

benchmark-maintains-buy-on-clene-lowers-price-target-to-31
Benchmark Maintains Buy on Clene, Lowers P...
09/10/2025 12:21:40

Benchmark analyst Bruce D. Jackson maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $33 to $31.

clene-files-prospectus-supplement-for-628m-shares
Clene Files Prospectus Supplement For $6.2...
09/05/2025 20:28:05

 - SEC Filing

clene-inc-announces-new-preclinical-data-showing-that-its-lead-candidate-cnm-au8-improved-cellular-health-in-a-dopaminergic-neuron-model-of-parkinsons-disease
Clene Inc Announces New Preclinical Data S...
09/04/2025 12:38:41

Novel human preclinical neuronal model for Parkinson's disease demonstrated CNM-Au8's ability to improve mitochondrial ...

d-boral-capital-maintains-buy-on-clene-maintains-23-price-target
D. Boral Capital Maintains Buy on Clene, M...
08/21/2025 11:49:27

D. Boral Capital analyst Jason Kolbert maintains Clene (NASDAQ:CLNN) with a Buy and maintains $23 price target.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/20/2025 12:08:41

canaccord-genuity-maintains-buy-on-clene-lowers-price-target-to-48
Canaccord Genuity Maintains Buy on Clene, ...
08/18/2025 12:00:54

Canaccord Genuity analyst Sumant Kulkarni maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $83 to $48.

d-boral-capital-maintains-buy-on-clene-maintains-23-price-target
D. Boral Capital Maintains Buy on Clene, M...
08/14/2025 16:08:41

D. Boral Capital analyst Jason Kolbert maintains Clene (NASDAQ:CLNN) with a Buy and maintains $23 price target.

clene-q2-eps-078-misses-047-estimate-sales-27000k-miss-52833k-estimate
Clene Q2 EPS $(0.78) Misses $(0.47) Estima...
08/14/2025 12:44:40

Clene (NASDAQ:CLNN) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.47) by 64...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
07/18/2025 21:06:22

d-boral-capital-maintains-buy-on-clene-maintains-23-price-target
D. Boral Capital Maintains Buy on Clene, M...
07/18/2025 12:41:17

D. Boral Capital analyst Jason Kolbert maintains Clene (NASDAQ:CLNN) with a Buy and maintains $23 price target.

d-boral-capital-maintains-buy-on-clene-maintains-23-price-target
D. Boral Capital Maintains Buy on Clene, M...
06/30/2025 17:06:18

D. Boral Capital analyst Jason Kolbert maintains Clene (NASDAQ:CLNN) with a Buy and maintains $23 price target.

clene-inc-regains-listing-on-nasdaq
Clene Inc Regains Listing On Nasdaq
06/17/2025 20:34:40

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/16/2025 21:05:53

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 17:06:51

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 12:07:39

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/02/2025 21:05:57

benchmark-maintains-buy-on-clene-lowers-price-target-to-33
Benchmark Maintains Buy on Clene, Lowers P...
05/08/2025 14:05:24

Benchmark analyst Bruce Jackson maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $84 to $33.

d-boral-capital-maintains-buy-on-clene-maintains-23-price-target
D. Boral Capital Maintains Buy on Clene, M...
05/08/2025 11:28:36

D. Boral Capital analyst Jason Kolbert maintains Clene (NASDAQ:CLNN) with a Buy and maintains $23 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION